Literature DB >> 33295742

Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review.

Martina Sanlorenzo1, Simone Ribero2, Simona Osella Abate2,3, Sara Mariani3, Paolo Strignano4, Mauro Salizzoni4, Paola Savoia2, Maria T Fierro2, Pietro Quaglino2.   

Abstract

The most frequent genetic aberrations in mucosal melanoma are activating mutations of c-KIT. Primary malignant melanomas of esophagus (PMME) are uncommon entities, with aggressive biological behavior and poor prognosis. The better definition of their genotype could improve therapeutic options. We report a case of a 66 years old man with a PMME in the lower third of the esophagus. Analysis of c-kit, KRAS, NRAS and BRAF genes resulted negative for mutations. On the basis of a computerized (PuMed/Medline) bibliography search we retrieved a total of other 35 cases of PMME analyzed for genetic alterations in RAS, BRAF, and KIT. When we compared mutations frequency of PMME with those of other mucosal melanomas, it appeared that PMME are characterized by a relative higher percentage of NRAS mutations. PMME seem to show a specific pattern of genetic alterations suggesting that they could represent a distinct entity among mucosal melanomas.

Entities:  

Year:  2015        PMID: 33295742     DOI: 10.23736/S0392-0488.16.05174-9

Source DB:  PubMed          Journal:  G Ital Dermatol Venereol        ISSN: 0392-0488            Impact factor:   2.011


  2 in total

1.  Primary malignant melanoma of esophagus shared similar genetic characters with both cutaneous and oral mucosal melanoma.

Authors:  Jingjing Li; Shi Yan; Nan Wu
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 2.  The Thousand Faces of Malignant Melanoma: A Systematic Review of the Primary Malignant Melanoma of the Esophagus.

Authors:  Gerardo Cazzato; Eliano Cascardi; Anna Colagrande; Teresa Lettini; Leonardo Resta; Cinzia Bizzoca; Francesca Arezzo; Vera Loizzi; Miriam Dellino; Gennaro Cormio; Nadia Casatta; Carmelo Lupo; Antonio Scillimati; Salvatore Scacco; Paola Parente; Lucia Lospalluti; Giuseppe Ingravallo
Journal:  Cancers (Basel)       Date:  2022-07-30       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.